Design of Anti-ischemic drug based on their effects in liver mitochondria of the turtle as an anaerobiosis model.
基于对厌氧模型龟肝线粒体的影响设计抗缺血药物。
基本信息
- 批准号:02671001
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1990
- 资助国家:日本
- 起止时间:1990 至 1991
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We designed the following compounds : 1)salicylanilides, 2)thiodiazoles, 3)vitarmin K_1 epoxides, 4)disacchatide sulfates of steroids and triterpenoids(eg. glycyrrhizinic acid), 5)disaccharide(maltose and isomaltose)sulfates, 6)cyclodextrin-steroid complex as candidates of anti-ischemic drugs. Especially we studied the syntheses of new thiadiazole compounds such as TX-101-TX-109, their efftects against the respiratory activity in liver mitochondm in turtle as well as rat, and their in vivo anti-ischemic activity in mouse. We often used the UV detector for HPLC purchased by this grant detect our developed synthetic compounds for their isolation, analysis, and purification. As bioassay, we developed the aninmal model of anti-ischemic drug research using freshwater turtles(Mauremys japonica and Chineinys reevesii)as an animal anaerobe. The liver mitochondria were isolated from liver in turtle which was under hibernation, the RCI(Respiratory Control Index)of which was ca. 3. The mitochondrial function(oxygen consumption and ATP synthesis)was measured in our newly developed cell connected with high-sensitive sensors such as oxygen, pH, and membrane potential. TX-109 uncoupled the mitochondrial oxidative phosphorylation strongly[25nM(Vox max : 14natoms O/min/mg protein)]. This concentration of uncoupling activity in turtle liver mitochondria was similar, but its rate of oxygen consumption at this state was slower, in comparison with those in rat[TX-109 : 45nM(Vox max : 340natoms O/min/mg protein)]. These thiodiazole derivatives TX-101-109 showed weak anti-ischemic activities in vivo at the concentration of l00mg/kg i. p. We approached to develop the animal model using turtle live mitochondria and apply to the development of antiischemic drugs.
我们设计了以下化合物:1)水杨酰苯胺,2)硫代二唑,3)维生素K_1环氧化物,4)类固醇和三萜类化合物(例如甘草酸)的二糖苷硫酸盐,5)二糖(麦芽糖和异麦芽糖)硫酸盐,6)环糊精-类固醇复合物作为抗缺血的候选化合物 药物。特别是研究了TX-101-TX-109等新型噻二唑化合物的合成、它们对乌龟和大鼠肝线粒体呼吸活性的影响以及它们在小鼠体内的抗缺血活性。我们经常使用本次资助购买的 HPLC 紫外检测器来检测我们开发的合成化合物,以进行分离、分析和纯化。作为生物测定,我们以淡水龟(日本毛龟和中国龟)作为厌氧动物,建立了抗缺血药物研究的动物模型。从冬眠龟的肝脏中分离出肝线粒体,其RCI(呼吸控制指数)约为。 3. 在我们新开发的细胞中测量线粒体功能(耗氧量和 ATP 合成),并连接氧气、pH 和膜电位等高灵敏度传感器。 TX-109 强烈解偶联线粒体氧化磷酸化[25nM(Vox max:14natoms O/min/mg 蛋白质)]。龟肝线粒体中的解偶联活性浓度相似,但与大鼠相比,该状态下的耗氧速率较慢[TX-109:45nM(Vox max:340natoms O/min/mg Protein)]。这些硫代二唑衍生物TX-101-109在l00mg/kg i浓度下在体内表现出弱的抗缺血活性。 p。我们尝试利用海龟活线粒体开发动物模型,并将其应用于抗缺血药物的开发。
项目成果
期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hiroshi Terada: Hirokawa Publishing Co. The Second Series of Pharmaceutical Research and Development-23 volumes Volume 5 : Separation and purification of bioactive compounds, 380 (1991)
寺田浩:广川出版公司药物研究与开发第二辑-23卷第5卷:生物活性化合物的分离和纯化,380(1991)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hiromu Satake: "A coated wire electrode sensitive to tetraphenyl-phosphonium ion for measurement of the mitochondrial membrane potential" Analytical Letters. 24. 295-304 (1991)
Hiromu Satake:“一种对四苯基鏻离子敏感的涂层线电极,用于测量线粒体膜电位”分析快报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Satoru Goto,Zongru Guo,Yukako Futatsuishi,Hitoshi Hori,Zenei Taira,Hiroshi Terada: "Structure characteristics of benzamide type leukotriene antagonists and their biological activities" J.Medicinal Chemistry. 35. (1992)
Satoru Goto,Zongruuo,Yukako Futatsuishi,Hitoshi Hori,Zenei Taira,Hiroshi Terada:“苯甲酰胺型白三烯拮抗剂的结构特征及其生物活性”J.药物化学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Haruyuki Fukuda: "Radiosensitizing effects of nitroimidazole Derivatives RP170 and KIH-802." J. Osaka City Medical Center. 39. 575-593 (1990)
Haruyuki Fukuda:“硝基咪唑衍生物 RP170 和 KIH-802 的放射增敏作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hideko Nagasawa: "Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as functional radiosensitizers/chemical modifiers" Int'l. Radiation Oncology Biol. Phys.22. (1992)
Hideko Nagasawa:“硝基咪唑异羟肟酸酯类似物作为功能性放射增敏剂/化学改性剂的放射增敏、毒理学和药代动力学特性” Intl。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORI Hitoshi其他文献
HORI Hitoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORI Hitoshi', 18)}}的其他基金
Development of boron trace drug with broad molecule pursuit and destructive power by neutron irradiation
中子辐照开发具有宽分子追踪和破坏力的硼微量药物
- 批准号:
24659566 - 财政年份:2012
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Design of hypoxic cell radiosensitizer utilized for hypoxia orientation of macrophage
用于巨噬细胞缺氧定向的缺氧细胞放射增敏剂的设计
- 批准号:
14370758 - 财政年份:2002
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular design of anticancer drug, α-NaGalase inhibitors for immunopotentiation
抗癌药物、免疫增强α-NaGalase抑制剂的分子设计
- 批准号:
10672090 - 财政年份:1998
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Slow-growth/hypoxic cell-directed design of multifunctional antitumor agents
多功能抗肿瘤药物的慢生长/缺氧细胞定向设计
- 批准号:
08672561 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




